Join Newsletter

BS Medicine Podcast

Hosted by James McCormack and Mike Allan

These podcasts promote healthy skepticism and critical thinking, with the majority presented in a case-based format.

Recommended Listening

Episode 598: Insomnia – hours of sleep is not the goal! – PART II

In episode 598, James and Mike continue to talk with David Gardner about the issue of insomnia. We discuss his latest, very cool, Your Answers When Needing Sleep (YAWNS NB) randomized clinical trial. YAWNS was a pragmatic, open-label, minimum-contact, RCT where people with long-term use of benzodiazepines and current or past insomnia were randomly allocated […]...

Listen

Episode 597: Insomnia – hours of sleep is not the goal!

In episode 597, James and Mike invite David Gardner to talk in depth about the issue of insomnia. We talk about triggers, precipitating factors, acute and chronic insomnia, and chronic use of sleeping pills. We discuss Cognitive Behavioral Therapy for Insomnia (CBT-I) and how his team has developed a comprehensive website, Sleepwell, that provides patients […]...

Listen

Episode 595: How to slow the flow: Combined oral contraceptives

In episode 595, Mike and James invite Jennifer Young back to talk about the use of combined oral contraceptives for heavy menstrual bleeding (benign etiology) and see if they improve patient outcomes. They do! Have a listen to get all the numbers and see how they compare to using levonorgestrel-containing intrauterine devices or NSAIDs. Show […]...

Listen

Episode 594: Bumpin’ Up the Protection? RSV Vaccine in Pregnancy

In episode 594, Mike and James invite Samantha Moe back to talk about the use of the RSV vaccine in pregnancy. The only way to have an informed conversation around this vaccine is to know the numbers. If you listen to the whole podcast, you’ll get all the numbers available to date. Show notes Tools […]...

Listen

Episode 593: Tony Romo-sozumab: Winning touchdown in osteoporosis or interception for the loss?

In episode 593, Mike and James invite Samantha Moe back to talk about a newer agent for osteoporosis. So, if you want to know all the evidence for romosozumab, tune in and all will be revealed about the benefits and harms. Show notes 1) Tools for Practice Tony Romo-sozumab: Winning touchdown in osteoporosis or interception […]...

Listen

...

Listen

Sign Up for the PEER Newsletter

Don’t miss out on the latest from PEER. Get first access the latest PEER research and notified when PEER releases new guidelines and tools.